191 related articles for article (PubMed ID: 21791943)
1. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer.
Chen Y; Cui T; Yang L; Mireskandari M; Knoesel T; Zhang Q; Pacyna-Gengelbach M; Petersen I
Oncology; 2011; 80(5-6):333-40. PubMed ID: 21791943
[TBL] [Abstract][Full Text] [Related]
2. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of basal cytokeratin expression in breast cancer.
Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
[TBL] [Abstract][Full Text] [Related]
4. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
5. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratins and lung carcinomas.
Nhung NV; Mirejovský P; Mirejovský T; Melínová L
Cesk Patol; 1999 Jul; 35(3):80-4. PubMed ID: 11038661
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.
Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL
Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin expression profile in gastric carcinomas.
Kim MA; Lee HS; Yang HK; Kim WH
Hum Pathol; 2004 May; 35(5):576-81. PubMed ID: 15138932
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
Völkel C; De Wispelaere N; Weidemann S; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Krech RH; Dum D; Krech T; Marx AH; Simon R; Burandt E; Menz A
Virchows Arch; 2022 Feb; 480(2):433-447. PubMed ID: 34559291
[TBL] [Abstract][Full Text] [Related]
10. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
[TBL] [Abstract][Full Text] [Related]
11. Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas.
Camilo R; Capelozzi VL; Siqueira SA; Del Carlo Bernardi F
Hum Pathol; 2006 May; 37(5):542-6. PubMed ID: 16647951
[TBL] [Abstract][Full Text] [Related]
12. Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma.
Saintigny P; Coulon S; Kambouchner M; Ricci S; Martinot E; Danel C; Breau JL; Bernaudin JF
Int J Cancer; 2005 Jul; 115(5):777-82. PubMed ID: 15729695
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis.
Li YP; Jia XP; Jiang YQ; Wang W; Wang YL; Wang XL; Guo YX
Exp Biol Med (Maywood); 2018 Feb; 243(4):344-349. PubMed ID: 29350066
[TBL] [Abstract][Full Text] [Related]
14. If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung.
Downey P; Cummins R; Moran M; Gulmann C
APMIS; 2008 Jun; 116(6):526-9. PubMed ID: 18754327
[TBL] [Abstract][Full Text] [Related]
15. Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin.
Dogu GG; Ozkan M; Ozturk F; Dikilitas M; Er O; Ozturk A
Med Oncol; 2010 Mar; 27(1):34-9. PubMed ID: 19156550
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer].
Kosacka M; Jankowska R
Pneumonol Alergol Pol; 2007; 75(4):317-23. PubMed ID: 18080980
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin expression patterns in the rat respiratory tract as markers of epithelial differentiation in inhalation toxicology. I. Determination of normal cytokeratin expression patterns in nose, larynx, trachea, and lung.
Schlage WK; Bülles H; Friedrichs D; Kuhn M; Teredesai A
Toxicol Pathol; 1998; 26(3):324-43. PubMed ID: 9608639
[TBL] [Abstract][Full Text] [Related]
18. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns.
Franchi A; Moroni M; Massi D; Paglierani M; Santucci M
Am J Surg Pathol; 2002 Dec; 26(12):1597-604. PubMed ID: 12459626
[TBL] [Abstract][Full Text] [Related]
19. Compensation of type I and type II cytokeratin pools in lung cancer.
Kanaji N; Bandoh S; Fujita J; Ishii T; Ishida T; Kubo A
Lung Cancer; 2007 Mar; 55(3):295-302. PubMed ID: 17161499
[TBL] [Abstract][Full Text] [Related]
20. The prognostic application of cytokeratin typing of nonsmall cell lung carcinoma. A retrospective study.
Cohen R; Guber A; Siegal A; Bruderman I; Huszar M; Yellin A; Marom Z; Geiger B
Cancer; 1997 Feb; 79(3):468-73. PubMed ID: 9028356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
